Pivalde, I remember noting about a year or so ago that Dr. Masters had formed an affiliation with a Chinese biotech company ( I don't recall the company name ) to conduct research for them at his Fleury Institute. You probably noted as I did the many Chinese Scientists/Technicians that are contributors to the research studies and published papers. That concerned/bothered me knowing he then owned the PBT2 patent and Alterity very likely was in his rear view mirror. Personally, I was disappointed to say the least, but we still own ATH434 which hopefully will take investors and those suffering from MSA and Parkinson's to a better place down the road.
ATH Price at posting:
0.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)